The procedures in case of ascites in patients with an advanced stage of gastric cancer;Postepowanie w przypadku wodobrzusza u chorych z zaawansowanym rakiem żoładka

Wspolczesna Onkologia

Volumn 11, Issue 6, 2007, Pages 312-317

  Wroński, Konrad ^a   Płuzański, Adam ^a   Jakubik, Jarosław ^a   Kaczmarek, Michał ^a   Jeziorski, Arkadiusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Ascites; Gastric cancer; Treatment

Indexed keywords

ABDOMINAL PRESSURE; ADVANCED CANCER; ARTICLE; ASCITES; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; INTERVIEW; LIVER METASTASIS; MALE; PATIENT SAFETY; PERITONEUM METASTASIS; PROGNOSIS; PUNCTURE; QUALITY OF LIFE; STOMACH CANCER; STOMACH PAIN; SURGICAL TECHNIQUE; SYMPTOMATOLOGY;

EID: 34848868094     PISSN: 14282526     EISSN: 14282526     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Plummer M, Franceschi S, Munoz N. Epidemiology of gastric cancer. IARC Sci Publ 2004; 157: 311-26.
2. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma - 2nd English edition Japanese Gastric. Gastric Cancer 1998; 1: 10-24.
3. Paramo JC, Gomez G. Dynamic CT in the preoperative evaluation of patients with gastric cancer: correlation with surgical findings and pathology. Ann Surg Oncol 1999; 6: 379-84.
4. D'Elia F, Zingarelli A, Palli D, Grani M. Hydro-dynamic CT preoperative staging of gastric cancer: correlation with pathological findings. A prospective study of 107 cases. Eur Radiol 2000; 10: 1877-85.
5. Adachi Y, Sakino I, Matsumata T, Iso Y, Yoh R, Kitano S, Okudaira Y. Preoperative assessment of advanced gastric carcinoma using computed tomography. Am J Gastroenterol 1997; 92: 872-5.
6. Kayaalp C, Arda K, Orug T, Ozcay N. Value of computed tomography in addition to ultrasound for preoperative staging of gastric cancer. Eur J Surg Oncol 2002; 28: 540-3.
7. Stell DA, Carter CR, Stewart I, Anderson JR. Prospective comparison of laparoscopy, ultrasonography and computed tomography in the staging of gastric cancer. Br J Surg 1996; 83: 1260-2.
8. Nozoe T, Matsumata T, Sugimachi K. Usefulness of preoperative transvaginal ultrasonography for women with advanced gastric carcinoma. Am J Gastroenterol 1999; 94: 2509-12.
9. Chang DK, Kim JW, Kim BK, Lee KL, Song CS, Han JK, Song IS. Clinical significance of CT-defined minimal ascites in patients with gastric cancer. World J Gastroenterol 2005; 42: 6587-92.
10. Adam RA, Adam YG. Malignant ascites: past, present, and future. J Am Coll Surg 2004; 198: 999-1011.
11. Kodera Y, Nakanishi H, Yamamura Y, et al. Prognostic value and clinical implications of disseminated cancer cells in the peritoneal cavity detected by reverse transcriptase-polymerase chain reaction and cytology. Int J Cancer 1998; 79: 429-33.
12. Doust BD. The use of ultrasound in the diagnosis of gastroenterological disease. Gastroenterology 1976; 70: 602-10.
13. Habermann CR, Weiss F, Riecken R, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004; 230: 465-71.
14. Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006; 42: 589-97.
15. McNamara P. Paracentesis-an effective method of symptom control in the palliative care setting? Palliat Med 2000; 14: 62-4.
16. Gines P, Cardenas A, Arroyo V, Rodes J. Management of cirrhosis and ascites. N Engl J Med 2004; 350: 1646-54.
17. Ross GJ, Kessler HB, Clair MR, Gatenby RA, Hartz WH, Ross LV. Sonographically guided paracentesis for palliation of symptomatic malignant ascites. AJR Am J Roentgenol 1989; 153: 1309-11.
18. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007; 18: 945-9.
19. Gough IR, Balderson GA. Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management. Cancer 1993; 71: 2377-82.
20. Pollock AV. The treatment of resistant malignant ascites by insertion of a peritoneo-atrial Holter valve. Br J Surg 1975; 62: 104-7.
21. Allon M, Soucie JM, Macon EJ. Complications with permanent peritoneal dialysis catheters: experience with 154 percutaneously placed catheters. Nephron 1988; 48: 8-11.
22. Gough IR. Control of malignant ascites by peritoneovenous shunting. Cancer 1984; 54: 2226-30.
23. Faught W, Kirkpatrick JR, Krepart GV, Heywood MS, Lotocki RJ. Peritoneovenous shunt for palliation of gynecologic malignant ascites. J Am Coll Surg 1995; 180: 472-4.
24. Souter RG, Train D, Kettlewell MG. Peritoneovenous shunts in the malignant ascites. Br J Surg 1983; 70: 478-81.
25. Jacobs IG, Cray RR, Elliott DS, Grosman H. Radiologic placement of peritoneal dialysis catheters: preliminary experience. Radiology 1992; 182: 251-5.
26. Savender SJ. Precutaneous radiologic placement of peritoneal dialysis catheters. J Vasc Interv Radiol 1999; 10: 249-56.
27. Lorentzen T, Sengeløv L, Nolsøe CP, Khattar SC, Karstrup S, von der Maase H. Ultrasonically guided insertion of a peritoneo-gastric shunt in patients with malignant ascites. Acta Radiol 1995; 36: 481-4.
28. O'Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Radiology 2001; 177: 615-8.
29. Savin MA, Kirsch MJ, Romano WJ, Wang SK, Arpasi PJ, Mazon CD. Peritoneal ports for treatment of intractable ascites. J Vasc Interv Radiol 2005; 16: 363-8.
30. Barnett TD, Rubins J. Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified precutaneous approach. J Vasc Interv Radiol 2002; 13: 379-83.
31. Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol 2006; 24: 4011-9.
32. Kunisaki C, Shimada H, Akiyama H, Nomura M, Matsuda G, Otsuka Y, Ono H, Takahashi M. Therapeutic outcomes of continuous hyperthermic peritoneal perfusion against advanced gastric cancer with peritoneal carcinomatosis. Hepatogastroenterology 2006; 53: 473-8.
33. Howell SB, Pfeifle CL, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M. Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 1982; 97: 845-51.
34. Markman M, Rowinsky E, Hakes T, et al. Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J Clin Oncol 1992; 10: 1485-91.
35. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995; 332: 1004-14.
36. Lopez JA, Krikorian JG, Reich SD, Smyth RD, Lee FH, Issell BF. Clinical pharmacology of intraperitoneal cisplatin. Gynecol Oncol 1985; 20: 1-9.
37. Schneider JG. Intraperitoneal chemotherapy. Obstet Gynecol Clin North Am 1994; 21: 195-212.
38. Francis P, Rowinsky E, Schneider J, Hakes T, Hoskins W, Markman M. Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study. J Clin Oncol 1995; 13: 2961-7.
39. Kunisaki C, Shimada H, Nomura M, Akiyama H, Takahashi M, Matsuda G. Lack of efficacy of prophylactic continuous hyperthermic peritoneal perfusion on subsequent peritoneal recurrence and survival in patients with advanced gastric cancer. Surgery 2002; 131: 521-8.
40. Urano M, Kuroda M, Nishimura Y. For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 1999; 15: 79-107.
41. Beaujard AC, Glehen O, Caillot JL, et al. Intraperitoneal chemohyperthermia with mitomycin C for digestive tract cancer patients with peritoneal carcinomatosis. Cancer 2000; 88: 2512-9.
42. Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, Ohkubo H. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992; 70: 2754-60.
43. Yajima K, Kanda T, Ohashi M, Wakai T, Nakagawa S, Sasamoto R, Hatakeyama K. Clinical and diagnostic significance of preoperative computed tomography findings of ascites in patients with advanced gastric cancer. Am J Surg 2006; 192: 185-90.
44. Toyokawa T, Sawada T, Muguruma K, et al. A case of advanced gastric cancer with malignant ascites responding to weekly paclitaxel therapy. Gan To Kagaku Ryoho 2006; 33: 1637-40.
45. Imamura H, Furukawa H, Kishimoto T, et al. A case of complete remission of carcinomatous ascites refractory for TS-1 monotherapy treated with TS-1 plus paclitaxel combined therapy for gastric cancer. Gan To Kagaku Ryoho 2006; 33: 1900-3.
46. Sugihara S, Ikuta Y, Kobayashi H, Tsuruta Y, Yonemitsu K, Toyama E, Teshima K. Effective TS-1 + paclitaxel administration for gastric cancer with malignant ascites. Gan To Kagaku Ryoho 2005; 32: 2109-11.
47. Ohtani S, Shimizu Y, Sugiyama S, Miyade Y, Ninomiya M. A case of advanced gastric cancer with carcinomatous ascites successfully treated by outpatient chemotherapy. Gan To Kagaku Ryoho 2007; 34: 85-7.
48. Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology 1992; 103: 1302-6.
49. Greenway B, Johnson PJ, Williams R. Control of malignant ascites with spironolactone. Br J Surg 1982; 69: 441-2.
50. Wroński K, Płuzański A. Wodobrzusze u chorych z rakiem żoładka. Onkol Pol 2007; 10: 19-23.